There was a lot of discussion last month around the announcement of the NHS Long Term Plan and what this means for general practice— Dr Jonathan Griffiths reflects on this in the View from the ground piece. Further details have since emerged in the form of a 5-year GP General Medical Services (GMS) contract framework from 2019/20. The contract provides details on the funding support available for over 20,000 additional primary care staff, to include clinical pharmacists, physician associates, physiotherapists, community paramedics, and social prescribing link workers.
The integration of clinical pharmacists in general practice started several years ago and the positive impact of this is starting to be realised. We have therefore commissioned a new series—Pharmacist focus—in which we aim to share details of how practice-based pharmacists can support the management of patients with chronic conditions. This issue includes the first clinical piece in this series, which focuses on type 2 diabetes.
Involving practice pharmacists in the care of people with type 2 diabetes has the potential to improve health outcomes for patients and reduce GP workload, while providing value for money to practices through meeting QOF requirements and cost-effective prescribing. Muhammad Siddiqur Rahman discusses the important role that practice pharmacists have in supporting people who are at high risk of developing type 2 diabetes, reviewing patients who have a new diagnosis of type 2 diabetes, and the ongoing management of patients with type 2 diabetes. The article serves as a guide for clinical practice pharmacists who are keen to get involved in running diabetes clinics, as well as GPs and other practice staff who are seeking the support of clinical practice pharmacists in their practice to help manage workload.